Position in ADCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,210
-$8,040 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 113 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $116,301,284 across 50 Drug Manufacturers - Specialty & Generic names. ADCT ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
7,116,095 | $66,393,166 | |
| 2 | ZTS |
Zoetis Inc.
|
191,729 | $13,777,645 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
332,250 | $11,256,629 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
179,743 | $8,496,451 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
33,495 | $5,645,247 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
4,777 | $2,588,321 | |
| 7 | VTRS |
Viatris Inc
|
136,476 | $2,167,238 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
110,479 | $1,912,391 |
All Filings in ADCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,210 | 3,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,250 | 3,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,590 | 3,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,000 | 3,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,040 | 3,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||